Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Strontium ranelate is no longer available for treatment.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Ixekizumab has known and some unexpected side effects.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Ruxolitinib can cause a delayed skin reaction on the nose.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Doctors should collaborate with the patient's primary care physician to decide if it's safe to stop taking Plavix before hair restoration surgery, considering the risk and benefit.

Warfarin is effective but risky, requiring careful monitoring to prevent bleeding.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.